Aurelia Private Equity
5
3M
4
0.23
1
0.20
1
- Stages of investment
- Areas of investment
Summary
In 2000 was created Aurelia Private Equity, which is appeared as VC. The venture was found in Europe in Germany. The main department of described VC is located in the Frankfurt.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Messaging. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Among the most popular portfolio startups of the fund, we may highlight MerLion Pharma, GILUPI, Combinature Biopharm.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Aurelia Private Equity, startups are often financed by Zu00fcrcher Kantonal Bank, Temasek Holdings, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are BC Brandenburg Capital, Viroad Biotechnology, Rosetta Capital. In the next rounds fund is usually obtained by Innoven Partners, Generis Capital Partners, Brandenburg Kapital.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2010. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2016. Comparing to the other companies, this Aurelia Private Equity performs on 9 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.23
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (3)
- 3D Technology (2)
- Messaging (2)
- Music (2)
- Pharmaceutical (1) Show 3 more
- Investments by region
-
- Germany (4)
- Singapore (1)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 0.80
- Avg. company exit year
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| GILUPI | 13 Jan 2011 | Biotechnology, Health Care, Medical Device, Medical | Late Stage Venture | 4M | Brandenburg, Potsdam, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.